"Secondary Prevention" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The prevention of recurrences or exacerbations of a disease or complications of its therapy.
| Descriptor ID |
D055502
|
| MeSH Number(s) |
E02.897 N02.421.726.825 N06.850.780.750
|
| Concept/Terms |
Secondary Prevention- Secondary Prevention
- Prevention, Secondary
- Preventions, Secondary
- Secondary Preventions
- Secondary Disease Prevention
- Disease Prevention, Secondary
- Disease Preventions, Secondary
- Prevention, Secondary Disease
- Preventions, Secondary Disease
- Secondary Disease Preventions
Relapse Prevention- Relapse Prevention
- Prevention, Relapse
- Preventions, Relapse
- Relapse Preventions
Early Therapy- Early Therapy
- Early Therapies
- Therapies, Early
- Therapy, Early
|
Below are MeSH descriptors whose meaning is more general than "Secondary Prevention".
Below are MeSH descriptors whose meaning is more specific than "Secondary Prevention".
This graph shows the total number of publications written about "Secondary Prevention" by people in this website by year, and whether "Secondary Prevention" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 4 | 4 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 5 | 5 |
| 2003 | 0 | 7 | 7 |
| 2004 | 0 | 3 | 3 |
| 2005 | 1 | 4 | 5 |
| 2006 | 0 | 6 | 6 |
| 2007 | 0 | 4 | 4 |
| 2008 | 1 | 6 | 7 |
| 2009 | 1 | 7 | 8 |
| 2010 | 0 | 7 | 7 |
| 2011 | 3 | 10 | 13 |
| 2012 | 2 | 4 | 6 |
| 2013 | 2 | 8 | 10 |
| 2014 | 1 | 4 | 5 |
| 2015 | 1 | 0 | 1 |
| 2016 | 4 | 3 | 7 |
| 2017 | 1 | 1 | 2 |
| 2018 | 4 | 2 | 6 |
| 2019 | 4 | 3 | 7 |
| 2020 | 2 | 1 | 3 |
| 2021 | 4 | 2 | 6 |
| 2022 | 0 | 3 | 3 |
| 2023 | 0 | 3 | 3 |
| 2024 | 2 | 3 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Secondary Prevention" by people in Profiles.
-
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Male and Female Patients: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial. JAMA Cardiol. 2024 Sep 01; 9(9):808-816.
-
Impact of aspirin dose according to race in secondary prevention of atherosclerotic cardiovascular disease: a secondary analysis of the ADAPTABLE randomised controlled trial. BMJ Open. 2024 Aug 07; 14(8):e078197.
-
Predictors of Shock-Reduction Programming and Its Impact on Implantable Cardioverter-Defibrillator Therapies and Mortality: The CERTITUDE Registry. J Am Heart Assoc. 2024 Aug 06; 13(15):e034500.
-
Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease. J Am Heart Assoc. 2024 Feb 20; 13(4):e026921.
-
Randomized Secondary Prevention Trials in Participants With Symptomatic Intracranial Atherosclerotic Stenosis. Stroke. 2024 02; 55(2):324-334.
-
Evidence-Based Approach for Secondary Prevention of Uterine Fibroids (The ESCAPE Approach). Int J Mol Sci. 2023 Nov 04; 24(21).
-
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients Treated With P2Y12 Inhibitors. J Am Heart Assoc. 2023 10 17; 12(20):e030385.
-
Comparison of the effectiveness and safety of 2 aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: A subgroup analysis of ADAPTABLE. Am Heart J. 2023 10; 264:31-39.
-
Highlights in ASCVD Primary Prevention for 2021. J Am Heart Assoc. 2022 07 05; 11(13):e025973.
-
Post-fracture care programs for prevention of subsequent fragility fractures: a literature assessment of current trends. Osteoporos Int. 2022 Aug; 33(8):1659-1676.